Dr. Dima Dandachi, MD
Claim this profileGSK Investigational Site
Studies Human Immunodeficiency Virus Infection
Studies Antiretroviral Therapy
6 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Dima Dandachi, MD is currently running
Accelerated ART Initiation
for HIV
The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a standardized method for outreach, the use of telehealth for rapid access to an HIV care provider, a simplified pre-approved HIV regimen, a free 30-day medication starter supply, and re-linkage to medical care.
Recruiting3 awards Phase 43 criteria
Clofazimine Inhalation
for Nontuberculous Mycobacterial Infections
This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)
Recruiting1 award Phase 33 criteria
More about Dima Dandachi, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Dima Dandachi, MD has experience with
- Reparixin
- Bictegravir/emtricitabine/tenofovir Alafenamide
- The Accelerate Model Of Care
- Matching Placebo
- Clofazimine Inhalation Suspension
- APRETUDE
Breakdown of trials Dima Dandachi, MD has run
Human Immunodeficiency Virus Infection
Antiretroviral Therapy
Skin and Soft Tissue Infections
Infections and Infestations
Assisted Reproductive Technology
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dima Dandachi, MD specialize in?
Dima Dandachi, MD focuses on Human Immunodeficiency Virus Infection and Antiretroviral Therapy. In particular, much of their work with Human Immunodeficiency Virus Infection has involved treating patients, or patients who are undergoing treatment.
Is Dima Dandachi, MD currently recruiting for clinical trials?
Yes, Dima Dandachi, MD is currently recruiting for 3 clinical trials in Columbia Missouri. If you're interested in participating, you should apply.
Are there any treatments that Dima Dandachi, MD has studied deeply?
Yes, Dima Dandachi, MD has studied treatments such as Reparixin, bictegravir/emtricitabine/tenofovir alafenamide, The Accelerate model of care.
What is the best way to schedule an appointment with Dima Dandachi, MD?
Apply for one of the trials that Dima Dandachi, MD is conducting.
What is the office address of Dima Dandachi, MD?
The office of Dima Dandachi, MD is located at: GSK Investigational Site, Columbia, Missouri 65212 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.